Under the guidance of Cheruba Prabakar, MD, a board certified OBGYN based in Lafayette, CA, the companies will study the effects of CBDV and CBC on menstrual pain and premenstrual pain symptoms over the course of two full menstrual cycles.
Open Book Extracts (Roxboro, NC) and Purissima, a multi-patented health and wellness biotechnology company, are recruiting participants for a placebo-controlled study that investigates the effects of the cannabinoids CBC and CBDV on menstrual pain relief in women. Under the guidance of Cheruba Prabakar, MD, a board certified OBGYN based in Lafayette, CA, the companies will study the effects of CBDV and CBC on menstrual pain and premenstrual pain symptoms over the course of two full menstrual cycles.
During the study, participants will take their usual PMS over-the-counter products for one month with the addition of a cannabinoid edible gummy during the second month, and report pain scores across period pain and other PMS symptoms. Also known as premenstrual syndrome, PMS is a complex combination of physical and emotional symptoms that women can experience one or two weeks prior to their period. The study participants will be between the ages of 18 and 35, and suffering from menstrual pain and PMS symptoms such as mood and bowel changes.
“For this study Open Book Extracts and Purissima want to reach women who take ibuprofen-type products such as Midol, a non-steroidal anti-inflammatory drug (NSAID), or other OTC products to alleviate their pain and symptoms or just wanted to try a natural pain reliever,” said Nicole Brown, chief innovation officer for Open Book Extracts, in a press release. “Many women have also tried ginger root, and other herbal supplements and CBD products for pain or other health concerns and are curious to explore alternatives.”
CBC and CBDV are known to have strong anti-inflammatory and pain-relieving properties. Those interested in participating can apply for the study here.